Amedisys Inc. buy Credit Suisse Group AG
Start price
28.02.23
/
50%
€85.50
Target price
28.02.24
€108.15
Performance (%)
-0.58%
End price
29.02.24
€85.00
Summary
This prediction ended on 29.02.24 with a price of €85.00. The BUY prediction by Credit_Suisse_Group_ for Amedisys Inc. closed nearly unchanged. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amedisys Inc. | - | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $115.00 price target on the stock.
Ratings data for AMED provided by MarketBeat
In the thread Trading Amedisys Inc.
Die von Credit_Suisse_Group_ gewählte maximale Laufzeit wurde überschritten